---
title: "Weekly Recap | Picard Medical -44.39%, spike-and-fade on heavy volume"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302953708.md"
description: "Picard Medical closed the week at $7.09, down 44.39%, against a 0.47% dip for the S&P 500 and underperforming by about 43.92 percentage points. Price action was a spike-and-fade: Monday (Oct 19) opened strong and closed at $15.45, Tuesday (Oct 20) hit an intraday high of $17.47 before reversing to $10.48, Wednesday (Oct 21) broke below $10, Thursday (Oct 22) touched $7.00, and Friday (Oct 23) settled at $7.09. Weekly amplitude was 77."
datetime: "2026-10-24T06:50:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302953708.md)
  - [en](https://longbridge.com/en/news/302953708.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302953708.md)
generator: "portal-rs"
---

# Weekly Recap | Picard Medical -44.39%, spike-and-fade on heavy volume

## The Week

Picard Medical closed the week at $7.09, down 44.39%, against a 0.47% dip for the S&P 500 and underperforming by about 43.92 percentage points. Price action was a spike-and-fade: Monday (Oct 19) opened strong and closed at $15.45, Tuesday (Oct 20) hit an intraday high of $17.47 before reversing to $10.48, Wednesday (Oct 21) broke below $10, Thursday (Oct 22) touched $7.00, and Friday (Oct 23) settled at $7.09. Weekly amplitude was 77.04%, and average daily volume of 520,954 shares ran about 91.37% above its 272,224 median, marking a heavy-volume week.\\n\\n## Key Events\\nThe company’s own news flow was light, but one regulatory filing contrasted with the price swings. On Friday, Oct 23, Picard Medical submitted an S-3 covering a 200,000-share issuance tied to warrants. Earlier in the week, the stock repeatedly surfaced on pre-market and intraday mover lists: up 12.63% in Monday’s pre-market, briefly above 20% intraday, then swinging lower on Tuesday through Friday with no major company announcement attached. After Friday’s close, the warrant-for-share exchange was disclosed. Overall, most headlines were about price volatility rather than operations; the warrant exchange was the only substantive company action in the window.\\n\\n## Analyst Ratings\\nCoverage is thin: one firm rates the stock, with a hold recommendation and no buy or sell ratings. The consensus target price is $0, which sits 100% below the latest close of $7.09; with just one covering firm and no target range, that figure has limited informational value. Within the medical devices industry, the stock ranks 133rd out of 142 names, reflecting sparse coverage rather than a meaningful shift in analyst direction.\\n\\n## The Week Ahead\\nNo directly scheduled corporate event lands next week. US macro releases from Monday Oct 26 to Tuesday Oct 27 include durable goods orders, consumer confidence, FHFA house prices, and new home sales, which set the tone for risk appetite around small-cap medical device names. The next company-specific catalyst comes on Thursday, Nov 19, after the close, when Picard Medical reports fiscal Q3 2026 results. Consensus estimates point to EPS of -$1.5 and revenue of $1.55 million.\\n\\n## In Short\\nThis week showed how fast a small-cap name can reprice: the stock fell from a $17.47 high back to the $7 area on sharply higher volume. The company carries a market value of roughly $16.6 million, a price-to-book ratio of about 9.66x, and negative EPS; analyst coverage stands at one hold rating, with the warrant exchange and the November earnings report as the visible catalysts. Latest-day capital flow showed small and medium orders acting as net sellers while large orders were essentially flat, suggesting low institutional participation. The focus now shifts from the price swing itself to the warrant exchange terms and whether the Q3 report adds clarity on revenue and cash burn.\\n\\n*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [PMI.US](https://longbridge.com/en/quote/PMI.US.md)

## Related News & Research

- [Picard Medical issues $1 million of 3% unsecured convertible notes to accredited investors](https://longbridge.com/en/news/301059666.md)
- [Picard Medical Lowers Shareholder Meeting Quorum Requirement](https://longbridge.com/en/news/301744862.md)
- [Tesla's China-made EV sales rise 10.3% y/y in October](https://longbridge.com/en/news/304090921.md)
- [Oracle Stock Price Forecast: $20 Billion Financing Plan Sends Stock Down Nearly 9%, ORCL Shares May Retreat Toward $100 Mark](https://longbridge.com/en/news/304066590.md)
- [Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116](https://longbridge.com/en/news/304145542.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**